Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeffrey Montgomery

Concepts (437)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
52
2024
158
9.840
 Why?
Cystectomy
31
2024
49
6.280
 Why?
Prostatic Neoplasms
43
2024
394
5.060
 Why?
Kidney Neoplasms
22
2018
174
2.770
 Why?
Carcinoma, Transitional Cell
13
2023
52
2.680
 Why?
Prostatectomy
22
2023
83
2.350
 Why?
Nephrectomy
19
2016
81
1.990
 Why?
Lymph Node Excision
7
2024
138
1.820
 Why?
Urinary Diversion
6
2021
44
1.630
 Why?
Prostate
14
2024
117
1.540
 Why?
Laparoscopy
13
2014
170
1.540
 Why?
Quality of Life
12
2023
844
1.450
 Why?
Aged
81
2024
9590
1.350
 Why?
Male
120
2024
25718
1.260
 Why?
Middle Aged
87
2024
12460
1.200
 Why?
Humans
149
2024
50389
1.180
 Why?
Neoadjuvant Therapy
12
2024
119
1.130
 Why?
Neoplasm Staging
25
2024
750
1.020
 Why?
BCG Vaccine
7
2024
16
0.980
 Why?
Robotics
8
2015
41
0.960
 Why?
Retrospective Studies
52
2024
6223
0.920
 Why?
Postoperative Complications
15
2021
1035
0.920
 Why?
Carcinoma, Renal Cell
10
2016
101
0.910
 Why?
Penile Neoplasms
3
2024
45
0.880
 Why?
Exercise Therapy
1
2023
94
0.820
 Why?
Ureter
3
2016
37
0.810
 Why?
Exercise
2
2023
505
0.810
 Why?
Hernia
2
2020
6
0.770
 Why?
Neoplasm Recurrence, Local
15
2024
634
0.710
 Why?
Intestine, Small
2
2020
111
0.710
 Why?
Treatment Outcome
30
2024
5230
0.690
 Why?
Herniorrhaphy
1
2020
26
0.690
 Why?
Physical Fitness
1
2020
56
0.690
 Why?
Intestinal Obstruction
1
2020
36
0.680
 Why?
Patient Readmission
6
2021
227
0.680
 Why?
Aged, 80 and over
26
2024
3180
0.660
 Why?
Image-Guided Biopsy
6
2024
33
0.660
 Why?
Watchful Waiting
7
2019
27
0.640
 Why?
Biopsy
17
2023
592
0.610
 Why?
Ureteral Neoplasms
2
2018
11
0.600
 Why?
Neoplasm Invasiveness
14
2024
269
0.600
 Why?
Female
59
2024
26981
0.580
 Why?
Magnetic Resonance Imaging
10
2023
1534
0.550
 Why?
Urinary Bladder
7
2018
93
0.550
 Why?
Testicular Neoplasms
4
2024
64
0.540
 Why?
Convalescence
1
2016
6
0.540
 Why?
Carcinoma, Squamous Cell
4
2024
325
0.530
 Why?
Neoplasms, Germ Cell and Embryonal
3
2024
36
0.500
 Why?
Prospective Studies
17
2024
2414
0.490
 Why?
Urothelium
4
2018
18
0.490
 Why?
Carcinoma in Situ
4
2024
73
0.480
 Why?
Chemotherapy, Adjuvant
8
2024
121
0.480
 Why?
Ileum
1
2014
87
0.460
 Why?
Urologic Neoplasms
3
2019
12
0.460
 Why?
Choline
3
2019
63
0.460
 Why?
Neoplasm Grading
13
2020
124
0.450
 Why?
Medical Oncology
4
2021
96
0.450
 Why?
Quality Indicators, Health Care
1
2013
86
0.410
 Why?
Needles
3
2021
24
0.400
 Why?
Administration, Intravesical
7
2024
16
0.390
 Why?
Urologic Surgical Procedures
3
2016
27
0.390
 Why?
Disease Progression
8
2024
823
0.390
 Why?
Antineoplastic Agents
3
2021
1178
0.390
 Why?
Lymphatic Metastasis
4
2024
227
0.380
 Why?
Biopsy, Needle
5
2021
182
0.370
 Why?
Survival Rate
9
2021
915
0.370
 Why?
Prostate-Specific Antigen
8
2021
47
0.370
 Why?
Testicular Diseases
1
2011
4
0.370
 Why?
Risk Assessment
10
2019
1258
0.370
 Why?
Urogenital Neoplasms
1
2010
9
0.360
 Why?
Tumor Burden
6
2016
131
0.360
 Why?
Magnetic Resonance Imaging, Interventional
4
2024
5
0.350
 Why?
Muscle Neoplasms
1
2010
16
0.350
 Why?
Registries
4
2023
539
0.340
 Why?
Fluorine Radioisotopes
2
2019
24
0.330
 Why?
Retroperitoneal Space
5
2016
32
0.330
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1003
0.330
 Why?
Adult
27
2024
13568
0.330
 Why?
Recovery of Function
2
2023
190
0.330
 Why?
Psoas Muscles
2
2021
2
0.320
 Why?
Self Report
1
2010
203
0.320
 Why?
Organ Sparing Treatments
4
2018
55
0.320
 Why?
Telomerase
2
2019
26
0.310
 Why?
Patient Selection
5
2019
257
0.310
 Why?
Urinary Incontinence
3
2023
38
0.300
 Why?
Deoxycytidine
3
2024
28
0.290
 Why?
Seat Belts
2
2017
17
0.290
 Why?
Child Restraint Systems
2
2017
18
0.290
 Why?
Urinary Catheterization
1
2007
24
0.290
 Why?
Positron-Emission Tomography
2
2019
289
0.290
 Why?
Urethral Stricture
1
2007
21
0.290
 Why?
Time Factors
13
2020
2934
0.280
 Why?
Primary Health Care
1
2011
364
0.280
 Why?
Rectum
2
2024
52
0.270
 Why?
Cohort Studies
8
2021
1426
0.270
 Why?
Tomography, X-Ray Computed
3
2021
1160
0.270
 Why?
Guideline Adherence
3
2017
133
0.270
 Why?
Length of Stay
6
2020
627
0.270
 Why?
Health Status
2
2015
299
0.260
 Why?
Pain Measurement
2
2017
248
0.260
 Why?
Patient Discharge
3
2017
322
0.250
 Why?
Kidney
4
2014
686
0.250
 Why?
Patient Participation
2
2016
68
0.250
 Why?
Bandages
1
2005
25
0.240
 Why?
Carcinoma
2
2018
139
0.240
 Why?
Adenoviridae
2
2024
49
0.240
 Why?
Surgical Wound Infection
1
2005
116
0.240
 Why?
Neurilemmoma
1
2004
24
0.230
 Why?
Quality Improvement
3
2016
206
0.230
 Why?
Antimetabolites, Antineoplastic
1
2024
37
0.230
 Why?
Age Factors
7
2021
1104
0.230
 Why?
Multivariate Analysis
8
2016
583
0.230
 Why?
Adenocarcinoma
3
2016
402
0.230
 Why?
Immunohistochemistry
5
2024
975
0.230
 Why?
Organoids
1
2024
36
0.230
 Why?
Venous Thrombosis
1
2005
88
0.230
 Why?
Perineum
1
2024
24
0.230
 Why?
Follow-Up Studies
9
2024
2219
0.220
 Why?
Antibiotic Prophylaxis
1
2024
61
0.220
 Why?
Decision Making
2
2016
273
0.220
 Why?
Clinical Competence
3
2016
397
0.210
 Why?
Practice Guidelines as Topic
2
2018
460
0.210
 Why?
Prognosis
9
2021
1979
0.200
 Why?
Urethra
3
2014
91
0.200
 Why?
Erectile Dysfunction
3
2023
87
0.200
 Why?
United States
12
2020
4913
0.200
 Why?
DNA, Neoplasm
2
2018
146
0.190
 Why?
Logistic Models
7
2021
900
0.190
 Why?
Vital Statistics
1
2021
3
0.190
 Why?
Mandatory Reporting
1
2021
12
0.190
 Why?
Feasibility Studies
2
2020
386
0.190
 Why?
Death Certificates
1
2021
17
0.190
 Why?
DNA Mutational Analysis
3
2018
176
0.190
 Why?
Birth Certificates
1
2021
20
0.190
 Why?
Cell Transdifferentiation
1
2021
8
0.180
 Why?
Cost-Benefit Analysis
2
2019
270
0.180
 Why?
Neuroendocrine Cells
1
2021
10
0.180
 Why?
Reproducibility of Results
7
2018
1201
0.180
 Why?
Urethral Diseases
2
2013
7
0.180
 Why?
Radiosurgery
1
2022
121
0.180
 Why?
Radiography, Abdominal
1
2020
27
0.180
 Why?
Mutation
5
2019
1292
0.180
 Why?
Reimbursement, Incentive
1
2020
13
0.170
 Why?
Genetic Vectors
1
2020
127
0.170
 Why?
Randomized Controlled Trials as Topic
4
2023
556
0.170
 Why?
Genetic Therapy
1
2020
118
0.170
 Why?
Ablation Techniques
1
2019
22
0.170
 Why?
Abdominal Pain
1
2020
83
0.170
 Why?
Venous Thromboembolism
1
2020
67
0.160
 Why?
Diagnosis, Differential
2
2020
1042
0.160
 Why?
Genetic Predisposition to Disease
5
2024
509
0.160
 Why?
Adjuvants, Immunologic
3
2024
51
0.160
 Why?
Urinary Tract
1
2018
26
0.160
 Why?
Forecasting
1
2019
147
0.160
 Why?
Lymphocytes
1
2019
154
0.160
 Why?
Predictive Value of Tests
6
2018
934
0.160
 Why?
Patient-Centered Care
1
2020
129
0.160
 Why?
Obesity
2
2006
1125
0.150
 Why?
RNA, Neoplasm
1
2018
45
0.150
 Why?
Genetic Heterogeneity
1
2018
18
0.150
 Why?
Drug Resistance, Neoplasm
1
2020
318
0.150
 Why?
Neutrophils
1
2019
148
0.150
 Why?
Programmed Cell Death 1 Receptor
1
2018
40
0.150
 Why?
Retroperitoneal Neoplasms
1
2018
20
0.150
 Why?
Orchiectomy
1
2018
41
0.150
 Why?
Transurethral Resection of Prostate
1
2018
10
0.150
 Why?
Internship and Residency
2
2021
444
0.150
 Why?
Pain, Postoperative
2
2016
163
0.150
 Why?
Body Size
1
2017
27
0.150
 Why?
Electronic Health Records
1
2020
214
0.140
 Why?
Quality Assurance, Health Care
1
2018
149
0.140
 Why?
Physician-Patient Relations
2
2016
143
0.140
 Why?
Anticoagulants
1
2020
254
0.140
 Why?
Databases, Factual
2
2021
667
0.140
 Why?
Inguinal Canal
1
2017
11
0.140
 Why?
Urodynamics
2
2014
23
0.140
 Why?
Sarcosine
1
2017
3
0.140
 Why?
Amino Acid Transport Systems
1
2017
5
0.140
 Why?
Body Height
1
2017
65
0.140
 Why?
Transcriptome
2
2018
316
0.140
 Why?
Carbon Radioisotopes
1
2017
53
0.140
 Why?
Safety
1
2017
77
0.140
 Why?
Guidelines as Topic
1
2017
110
0.140
 Why?
Disease-Free Survival
5
2016
450
0.140
 Why?
Replantation
1
2016
11
0.140
 Why?
Scrotum
2
2015
30
0.140
 Why?
Protons
1
2017
67
0.130
 Why?
Nomograms
1
2016
5
0.130
 Why?
Laparotomy
1
2016
35
0.130
 Why?
Natural Orifice Endoscopic Surgery
1
2016
4
0.130
 Why?
Research Report
1
2016
16
0.130
 Why?
Kaplan-Meier Estimate
5
2017
466
0.130
 Why?
Physicians
2
2016
229
0.130
 Why?
Urinary Retention
2
2007
7
0.130
 Why?
Patient Preference
1
2016
40
0.130
 Why?
Checklist
1
2016
30
0.130
 Why?
Ureteral Obstruction
1
2016
61
0.130
 Why?
Time-to-Treatment
1
2016
70
0.130
 Why?
Preoperative Period
3
2021
48
0.130
 Why?
Genital Neoplasms, Male
1
2015
2
0.120
 Why?
Paget Disease, Extramammary
1
2015
5
0.120
 Why?
Sensitivity and Specificity
5
2018
875
0.120
 Why?
Social Networking
1
2015
15
0.120
 Why?
Body Weight
1
2017
514
0.120
 Why?
Lymph Nodes
1
2017
258
0.120
 Why?
Feedback
1
2015
52
0.120
 Why?
Radiopharmaceuticals
1
2016
205
0.120
 Why?
Video Recording
1
2015
79
0.120
 Why?
Treatment Failure
2
2017
115
0.120
 Why?
Peer Group
1
2015
54
0.120
 Why?
Informed Consent
1
2015
97
0.120
 Why?
Papilloma, Inverted
1
2014
1
0.120
 Why?
Proto-Oncogene Proteins B-raf
1
2015
78
0.120
 Why?
Equipment Design
3
2021
290
0.120
 Why?
Computer Simulation
1
2015
284
0.110
 Why?
Proto-Oncogene Proteins p21(ras)
1
2014
66
0.110
 Why?
Matched-Pair Analysis
1
2013
11
0.110
 Why?
Blood Loss, Surgical
5
2016
72
0.110
 Why?
Kidney Diseases
1
2016
213
0.110
 Why?
Urinary Incontinence, Stress
1
2014
30
0.110
 Why?
Diffusion of Innovation
1
2013
45
0.110
 Why?
Adenoma
1
2015
112
0.110
 Why?
Body Mass Index
3
2020
669
0.110
 Why?
Carcinoma, Papillary
1
2014
49
0.110
 Why?
General Surgery
1
2015
107
0.110
 Why?
Technology Transfer
1
2013
2
0.110
 Why?
Longitudinal Studies
2
2018
709
0.110
 Why?
Mitomycin
1
2013
20
0.110
 Why?
Radiotherapy, Adjuvant
2
2018
60
0.100
 Why?
Severity of Illness Index
2
2014
963
0.100
 Why?
Accreditation
1
2013
60
0.100
 Why?
Education, Medical, Continuing
1
2013
68
0.100
 Why?
Peripheral Nerves
1
2013
48
0.100
 Why?
Operating Rooms
1
2012
27
0.100
 Why?
Community Health Centers
1
2012
30
0.100
 Why?
Referral and Consultation
2
2012
284
0.100
 Why?
Pathology, Clinical
1
2012
24
0.100
 Why?
Receptors, Androgen
2
2002
46
0.100
 Why?
Algorithms
1
2015
618
0.100
 Why?
Combined Modality Therapy
3
2021
641
0.100
 Why?
Neoplasms
1
2021
1237
0.090
 Why?
Risk Factors
5
2017
3692
0.090
 Why?
Perioperative Care
1
2011
42
0.090
 Why?
Seminal Vesicles
2
2022
13
0.090
 Why?
Skin Neoplasms
1
2015
487
0.080
 Why?
Multicenter Studies as Topic
2
2023
88
0.080
 Why?
Medicare
3
2020
245
0.080
 Why?
Phantoms, Imaging
2
2020
122
0.080
 Why?
Proportional Hazards Models
3
2016
418
0.080
 Why?
Markov Chains
2
2019
31
0.080
 Why?
Carboplatin
2
2022
51
0.080
 Why?
SEER Program
3
2014
93
0.080
 Why?
Immunotherapy
1
2010
235
0.080
 Why?
Postoperative Care
2
2020
105
0.080
 Why?
Healthcare Disparities
1
2011
279
0.070
 Why?
Ureteroscopy
1
2007
12
0.070
 Why?
Sarcopenia
2
2021
94
0.070
 Why?
Automobiles
2
2017
14
0.070
 Why?
Incidence
2
2021
1017
0.070
 Why?
Pandemics
2
2023
564
0.070
 Why?
Chi-Square Distribution
3
2013
280
0.070
 Why?
Diverticulum
1
2007
21
0.070
 Why?
Peritoneum
1
2007
17
0.070
 Why?
Cisplatin
2
2022
275
0.070
 Why?
Delphi Technique
2
2018
54
0.070
 Why?
Gene Amplification
2
2018
57
0.070
 Why?
Societies, Medical
2
2018
179
0.070
 Why?
Aftercare
2
2018
74
0.070
 Why?
Gene Expression Profiling
2
2024
1029
0.070
 Why?
Adrenalectomy
1
2006
35
0.070
 Why?
Postoperative Hemorrhage
1
2006
52
0.070
 Why?
Promoter Regions, Genetic
2
2019
467
0.070
 Why?
Case-Control Studies
3
2014
1148
0.060
 Why?
Sex Factors
2
2020
702
0.060
 Why?
Fibrin Tissue Adhesive
1
2005
12
0.060
 Why?
Tissue Adhesives
1
2005
13
0.060
 Why?
Hand
1
2005
50
0.060
 Why?
Intestines
1
2006
171
0.060
 Why?
Genomics
2
2018
284
0.060
 Why?
Suture Techniques
1
2005
59
0.060
 Why?
Renal Insufficiency
1
2005
108
0.060
 Why?
Diabetes Complications
1
2005
119
0.060
 Why?
Chromosomes, Human, Pair 12
1
2024
14
0.060
 Why?
Glomerular Filtration Rate
2
2016
114
0.060
 Why?
Vulnerable Populations
1
2024
46
0.060
 Why?
Drug Screening Assays, Antitumor
1
2024
131
0.060
 Why?
Superior Mesenteric Artery Syndrome
1
2004
4
0.060
 Why?
Mediastinal Neoplasms
1
2024
19
0.060
 Why?
Communication
2
2016
246
0.060
 Why?
Phenotype
2
2018
736
0.060
 Why?
Hernia, Inguinal
1
2004
18
0.060
 Why?
Intraoperative Complications
1
2005
113
0.060
 Why?
High-Throughput Nucleotide Sequencing
2
2015
168
0.060
 Why?
Child
3
2024
6877
0.050
 Why?
Cell Line, Tumor
2
2018
1399
0.050
 Why?
Neoplasms, Second Primary
1
2024
74
0.050
 Why?
Quality of Health Care
2
2015
184
0.050
 Why?
Ischemia
1
2004
153
0.050
 Why?
Papillomavirus Infections
2
2015
168
0.050
 Why?
Perioperative Period
2
2013
22
0.050
 Why?
Trinucleotide Repeats
1
2002
4
0.050
 Why?
Liver Cirrhosis
1
2005
229
0.050
 Why?
Chromosome Aberrations
1
2024
295
0.050
 Why?
Muscles
1
2022
104
0.050
 Why?
Odds Ratio
2
2014
551
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2002
66
0.050
 Why?
Smoking
1
2005
508
0.050
 Why?
Gallium Isotopes
1
2021
2
0.050
 Why?
Accidents, Traffic
2
2017
87
0.050
 Why?
Gallium Radioisotopes
1
2021
10
0.050
 Why?
Edetic Acid
1
2021
14
0.050
 Why?
Radiotherapy, Intensity-Modulated
2
2013
174
0.050
 Why?
Geography
1
2021
61
0.050
 Why?
Androgen Antagonists
1
2021
11
0.050
 Why?
Polymorphism, Single Nucleotide
1
2024
482
0.050
 Why?
Public Health
1
2023
205
0.050
 Why?
Quarantine
1
2021
12
0.050
 Why?
Internationality
1
2021
40
0.050
 Why?
Neoplasm Metastasis
2
2017
235
0.050
 Why?
Drug Dosage Calculations
1
2020
10
0.040
 Why?
Motion
1
2020
19
0.040
 Why?
Enoxaparin
1
2020
27
0.040
 Why?
Finite Element Analysis
1
2020
10
0.040
 Why?
Drug Monitoring
1
2020
78
0.040
 Why?
Fellowships and Scholarships
1
2021
118
0.040
 Why?
Pelvis
1
2020
67
0.040
 Why?
Young Adult
2
2024
4064
0.040
 Why?
DNA-Directed RNA Polymerases
1
2019
14
0.040
 Why?
Abdomen
1
2020
77
0.040
 Why?
Heparin
1
2020
91
0.040
 Why?
Postoperative Period
1
2020
170
0.040
 Why?
Social Behavior
1
2019
69
0.040
 Why?
Urine
1
2018
23
0.040
 Why?
Adolescent
2
2024
6475
0.040
 Why?
Cytodiagnosis
1
2018
42
0.040
 Why?
Diagnostic Errors
1
2018
66
0.040
 Why?
Single-Blind Method
1
2018
114
0.040
 Why?
Image Processing, Computer-Assisted
1
2019
242
0.040
 Why?
DNA Copy Number Variations
1
2018
109
0.040
 Why?
Genome, Human
1
2018
111
0.040
 Why?
Quality-Adjusted Life Years
1
2018
63
0.040
 Why?
Sequence Analysis, RNA
1
2018
88
0.040
 Why?
Delivery of Health Care, Integrated
1
2018
46
0.040
 Why?
Hospitalization
2
2017
668
0.040
 Why?
Health Services Accessibility
2
2012
420
0.040
 Why?
Random Allocation
1
2018
287
0.040
 Why?
Nephrons
1
2016
6
0.030
 Why?
Tissue Distribution
1
2017
167
0.030
 Why?
Consensus
1
2018
159
0.030
 Why?
Dose-Response Relationship, Drug
1
2020
1356
0.030
 Why?
Hospital Communication Systems
1
2016
5
0.030
 Why?
Coitus
1
2016
18
0.030
 Why?
Failure to Thrive
1
2016
19
0.030
 Why?
Salvage Therapy
1
2017
136
0.030
 Why?
Anastomosis, Surgical
1
2016
66
0.030
 Why?
Early Detection of Cancer
1
2018
165
0.030
 Why?
Creatinine
1
2016
144
0.030
 Why?
Radiometry
1
2017
123
0.030
 Why?
Cyclin-Dependent Kinase 4
1
2015
11
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2015
11
0.030
 Why?
Genes, erbB-1
1
2015
8
0.030
 Why?
Operative Time
1
2016
72
0.030
 Why?
Tape Recording
1
2015
6
0.030
 Why?
Fever
1
2016
110
0.030
 Why?
Molecular Imaging
1
2016
54
0.030
 Why?
Socioeconomic Factors
2
2011
590
0.030
 Why?
Learning Curve
1
2015
18
0.030
 Why?
Groin
1
2015
16
0.030
 Why?
Tissue Array Analysis
1
2015
45
0.030
 Why?
Oncology Service, Hospital
1
2014
14
0.030
 Why?
Clinical Trials, Phase III as Topic
1
2015
43
0.030
 Why?
Vinblastine
1
2014
23
0.030
 Why?
Europe
1
2014
77
0.030
 Why?
North America
1
2014
66
0.030
 Why?
Incontinence Pads
1
2014
2
0.030
 Why?
Regression Analysis
1
2015
396
0.030
 Why?
In Situ Hybridization
1
2014
64
0.030
 Why?
Kidney Failure, Chronic
1
2016
200
0.030
 Why?
Amino Acid Substitution
1
2014
81
0.030
 Why?
Personal Satisfaction
1
2014
77
0.030
 Why?
Gene Dosage
1
2014
78
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2018
830
0.030
 Why?
Anxiety
1
2016
278
0.030
 Why?
Methotrexate
1
2014
73
0.030
 Why?
Ultrasonography
1
2016
438
0.030
 Why?
United States Department of Veterans Affairs
1
2015
288
0.030
 Why?
Survivors
1
2014
120
0.030
 Why?
Papillomaviridae
1
2014
103
0.030
 Why?
Dysuria
1
2013
1
0.030
 Why?
Cluster Analysis
1
2014
231
0.030
 Why?
Sequence Analysis, DNA
1
2014
237
0.030
 Why?
Prevalence
1
2016
970
0.030
 Why?
Anesthesiology
1
2014
45
0.030
 Why?
Intention to Treat Analysis
1
2013
27
0.030
 Why?
Valsalva Maneuver
1
2013
9
0.030
 Why?
Stents
1
2016
347
0.030
 Why?
Diagnostic Tests, Routine
1
2013
29
0.030
 Why?
Paclitaxel
1
2013
83
0.030
 Why?
Health Services Research
1
2013
150
0.030
 Why?
Doxorubicin
1
2014
234
0.030
 Why?
Confidence Intervals
1
2013
154
0.030
 Why?
Antibiotics, Antineoplastic
1
2013
77
0.030
 Why?
Neutropenia
1
2013
114
0.030
 Why?
Thrombocytopenia
1
2013
84
0.030
 Why?
Survival Analysis
1
2014
671
0.020
 Why?
Attitude of Health Personnel
1
2015
349
0.020
 Why?
Angiomyolipoma
1
2012
10
0.020
 Why?
Unnecessary Procedures
1
2012
20
0.020
 Why?
Tertiary Care Centers
1
2012
76
0.020
 Why?
Neoplasm, Residual
1
2013
161
0.020
 Why?
Neoplasms, Multiple Primary
1
2012
43
0.020
 Why?
Pilot Projects
1
2014
704
0.020
 Why?
Biopsy, Fine-Needle
1
2012
108
0.020
 Why?
Patient Positioning
1
2011
32
0.020
 Why?
Urination Disorders
1
2010
23
0.020
 Why?
Disease Management
1
2012
175
0.020
 Why?
Organ Size
1
2010
223
0.020
 Why?
Comorbidity
1
2012
617
0.020
 Why?
Health Status Disparities
1
2011
196
0.020
 Why?
Intraoperative Period
1
2007
45
0.020
 Why?
Erythrocyte Transfusion
1
2006
50
0.020
 Why?
Costs and Cost Analysis
1
2006
92
0.020
 Why?
Decision Trees
1
2005
19
0.020
 Why?
Portal System
1
2005
17
0.020
 Why?
Collateral Circulation
1
2005
39
0.020
 Why?
Hypertension, Portal
1
2005
20
0.020
 Why?
Reoperation
1
2006
457
0.010
 Why?
Short Bowel Syndrome
1
2004
16
0.010
 Why?
Blood Transfusion
1
2005
127
0.010
 Why?
Necrosis
1
2004
175
0.010
 Why?
Liver Transplantation
1
2005
155
0.010
 Why?
Polymorphism, Genetic
1
2002
181
0.010
 Why?
Genetic Markers
1
2002
103
0.010
 Why?
Statistics, Nonparametric
1
2002
193
0.010
 Why?
Base Sequence
1
2002
657
0.010
 Why?
Polymerase Chain Reaction
1
2002
456
0.010
 Why?
Molecular Sequence Data
1
2002
799
0.010
 Why?
Montgomery's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (437) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department